Cover Image

Marine Streptomyces-Derived Lipids Inhibit SARS-CoV-2 3CLpro through In Vitro and Predicted Multi-Site Binding Mechanisms Supporting Information

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Dalisay, Doralyn
Format:	Recurso digital
Published:	Zenodo 2025
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Marine -Derived Lipids Inhibit SARS-CoV-2 3CLpro Through In Vitro and Predicted Multi-Site Binding Mechanisms.
by: Dalisay, Doralyn S, et al.
Published: (2026)

Identification of SARS-CoV-2 3CLpro inhibitors from marine actinomycetes through integrated phylogeny-based metabolomics with functional screening and bioinformatic analysis.
by: Dalisay, Doralyn S, et al.
Published: (2025)

Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease
by: Wenjin Li, et al.
Published: (2024)

Polysialosides Outperform Sulfated Analogs for Binding with SARS‐CoV‐2
by: Vinod Khatri, et al.
Published: (2025)

Selection and Characterization of SARS‐CoV‐2 Spike Binding Clickmers
by: Nima Moradzadeh, et al.
Published: (2026)

Marine-Derived Peptides from as Potential SARS-CoV-2 Mpro Inhibitors: An Approach.
by: Cañedo-Figueroa, David Mauricio, et al.
Published: (2025)

SARS‐CoV‐2 PLpro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment
by: Sara Protić, et al.
Published: (2024)

Unraveling the Mechanism of Drug Binding to SARS-CoV-2 RNA Pseudoknot with Thermodynamics-Driven Machine Learning
by: Ivonina, Mariia, et al.
Published: (2026)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel
Published: (2020)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas, et al.
Published: (2024)

Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
by: Gints Kalnins, et al.
Published: (2024)

Pomotrelvir and Nirmatrelvir Binding and Reactivity with SARS‐CoV‐2 Main Protease: Implications for Resistance Mechanisms from Computations
by: Johanna Schillings, et al.
Published: (2024)

Deep Neural Network-Based Prediction of B-Cell Epitopes for SARS-CoV and SARS-CoV-2: Enhancing Vaccine Design through Machine Learning
by: Shi, Xinyu, et al.
Published: (2024)

COVID ‐19 Dry Mouth Induced by SARS ‐ CoV ‐2 Not Binding Directly to ACE2 but Interacting Electrostatically With Lipid Raft in Salivary Glands
by: Hironori Tsuchiya
Published: (2025)

AbAffinity: A Large Language Model for Predicting Antibody Binding Affinity against SARS-CoV-2
by: Ashraf, Faisal Bin, et al.
Published: (2026)

Front Cover: Copper(II) Inhibition of the SARS‐CoV‐2 Main Protease
by: Roberto A. Garza‐López, et al.
Published: (2025)

Corrigendum: Corrigendum: Binding of Glycans to the SARS CoV‐2 Spike Protein, an Open Question: NMR Data on Binding Site Localization, Affinity, and Selectivity
Published: (2024)

Mechanisms and safety of air plasma inactivated SARS-CoV-2
by: Wang, Guiqiang, et al.
Published: (2023)

LL‐37 Inhibits TMPRSS2 ‐Mediated S2 ' Site Cleavage and SARS‐CoV‐2 Infection but Not Omicron Variants
by: Zhenfei Bi, et al.
Published: (2025)

Navigating the Universe of the Web Information in the Multimedia Classroom.
by: Edwards, Doralyn H.
Published: (1997)

Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
by: Monica Rosas‐Lemus, et al.
Published: (2025)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
by: Deborah L Burnett, et al.
Published: (2026)

In Vitro Diagnostics for SARS ‐ CoV ‐2 Infection Authorized in the United States and Approved in Japan
by: Mayumi Idei, et al.
Published: (2025)

Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP
by: Tingfu Du, et al.
Published: (2026)

Predicting potential SARS-CoV-2 spillover and spillback in animals
by: Tan, Zi Hian, et al.
Published: (2024)

Immunoassay Detection of SARS ‐ CoV ‐2 Using Monoclonal Antibody Binding to Viral Nucleocapsid Protein
by: Robert M. Hnasko, et al.
Published: (2025)

SARS-CoV-2 and Saliva: an update
by: Muniz, Isis de Araújo Ferreira, et al.
Published: (2020)

Structural Immunology of SARS‐CoV‐2
by: Meng Yuan, et al.
Published: (2024)

Demografía y SARS-CoV-2
by: Manuel Ordorica Mellado
Published: (2021)

Pandemia por SARS-CoV-2
by: Erina Petrera
Published: (2020)

In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor
by: Timoteo Delgado‐Maldonado, et al.
Published: (2025)

Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”
Published: (2026)

SARS-CoV-2 and ACE2 nexus
by: Arifuddin, Mehnaaz Sameera
Published: (2020)

Quantitative Prediction of Protein-Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV-2 Spike Protein RBD
by: Neander, Lenard, et al.
Published: (2024)

Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS ‐ CoV and SARS ‐ CoV ‐2
by: Alexandre Hassanin, et al.
Published: (2024)

Impact of SARS-CoV-2 on the Coronavirus Literature through Dynamic Topics
by: Ibai Guillen Pacho
Published: (2022)

PETRA: Pretrained Evolutionary Transformer for SARS-CoV-2 Mutation Prediction
by: Zou, Xu
Published: (2025)

Predicting SARS‐CoV‐2 Infection With Graph Attention Capsule Networks
by: Runjie Zhu, et al.
Published: (2026)

Amphibian‐Derived Peptides as Natural Inhibitors of SARS‐CoV‐2 Main Protease (M pro ): A Combined In Vitro and In Silico Approach
by: Roque Spinelli, et al.
Published: (2025)

Computational Repurposing of Relatively Large Drugs for the Receptor Binding Domain of SARS‐CoV‐2 Spike Protein
by: Mansour H. Almatarneh, et al.
Published: (2025)